))
Darryl Hudson is Developing Psilocybin-Based Therapeutics
Manage episode 382855065 series 3342868
内容由PsychedelicInvest.com提供。所有播客内容（包括剧集、图形和播客描述）均由 PsychedelicInvest.com 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.
Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.
GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.
50集单集
分享
